Discover 3,494 paid clinical trials in Torrance, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,494
Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma
for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05800405
Early Phase 1, Recruiting
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
for
Full Aniridia, Partial Aniridia
Location: Los Angeles CA, Cincinnati OH, Philadelphia PA
Sponsor: Clinical Research Consultants, Inc.
Sex: All
Age: 3+
Code: NCT01860612
Recruiting
Cognition and Imaging With Tigertriever
for
Stroke
Location: Los Angeles CA, Orange CA, Grand Rapids MI,
Sponsor: Rapid Medical
Sex: All
Age: 18 - 70+
Code: NCT05531461
Recruiting
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
for
Lymphoblastic Leukemia, Cancer Survivors, Aplastic Anemia,
Location: Duarte CA, Memphis TN, Philadelphia PA
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 10 - 30
Code: NCT05194397
Phase 2, Recruiting
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
for
Small Cell Lung Carcinoma, Neuroendocrine Neoplasms,
Location: Los Angeles CA, San Francisco CA, Phoenix AZ,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT05882058
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
for
Acute Myeloid Leukemia (AML)
Location: Los Angeles CA, Fairway KS, Houston TX, Augusta GA,
Sponsor: Bio-Path Holdings, Inc.
Sex: All
Age: 18+
Code: NCT02781883
Phase 2, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
for
High-grade Serous Ovarian Carcinoma (HGSOC),
Location: Los Angeles CA, Vancouver, Toronto, Hackensack NJ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06476808
Phase 1, Recruiting
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
for
Hepatocellular Carcinoma (HCC)
Location: Orange CA, Phoenix AZ, Seattle WA, Omaha NE, Houston TX,
Sponsor: RayzeBio, Inc.
Sex: All
Age: 18+
Code: NCT06726161
Phase 1, Phase 2, Recruiting
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Los Angeles CA, Duarte CA, Portland OR, Denver CO,
Sponsor: Vironexis Biotherapeutics Inc.
Sex: All
Age: 13 - 70+
Code: NCT06533579
Phase 1, Phase 2, Recruiting
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
for
Idiopathic Pulmonary Fibrosis (IPF)
Location: Los Angeles CA, Scottsdale AZ, Oklahoma City OK,
Sponsor: InSilico Medicine Hong Kong Limited
Sex: All
Age: 40+
Code: NCT05975983
Phase 2, Recruiting
Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)
for
Cardiac Amyloidosis
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT05139797
Recruiting
A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Los Angeles CA, Whittier CA, Baltimore MD
Sponsor: Zhejiang Haichang Biotech Co., Ltd.
Sex: All
Age: 18+
Code: NCT05267899
Phase 1, Recruiting
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
for
Renal Cell Carcinoma
Location: Los Angeles CA, La Jolla CA, Tucson AZ, Lone Tree CO,
Sponsor: HiberCell, Inc.
Sex: All
Age: 18+
Code: NCT06234605
Phase 1, Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Los Angeles CA, Buena Park CA, South Pasadena CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04510597
Phase 3, Recruiting
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
for
Cancer, Breast, Cancer, Lung, Cancer of Pancreas,
Location: Cerritos CA, Orlando FL, Manhasset NY
Sponsor: Coherent Biopharma (Hefei) Co., Ltd.
Sex: All
Age: 18+
Code: NCT05830097
Phase 1, Phase 2, Recruiting
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: Duarte CA, Irvine CA, Salt Lake City UT, Seattle WA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT04973605
Phase 1, Phase 2, Recruiting
CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin
for
Sarcoma
Location: Santa Monica CA, Seattle WA, Pittsburgh PA,
Sponsor: CBA Research
Sex: All
Age: 18+
Code: NCT03002805
Phase 1, Recruiting
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Location: Los Angeles CA, San Antonio TX, Houston TX,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05836324
Phase 1, Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: Los Angeles CA, Palo Alto CA, San Francisco CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05489705
Recruiting
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors